Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Immuniodeficiency Clinic, ECMC, Buffalo

Universtity of Rochester School of Medicine, Rochester

Clinical Trials Research Services, Pittsburgh

University of South Carolina, Columbia

Atlanta ID Group, Atlanta

Consultive Medicine, Daytona Beach

Infectious Diseases of NW Florida, Pensacola

The Kinder Medical Group, Miami

Northpoint Medical, PA, Fort Lauderdale

Palm Beach Center, West Palm Beach

Clinical Research of West Florida, Clearwater

Vanderbilt University, AIDS Clinical Trials Center, Nashville

University of Iowa, Division of Infectious Diseases, Iowa City

The CORE Center, Chicago

Northstar Medical Center, Chicago

St. Louis University, Center for Vaccine Dev., St Louis

Washington University School of Medicine, St Louis

Nemechek Health Renewal, Kansas City

Health for Life Clinic, PLLC, Little Rock

University of Oklahoma, Oklahoma City

Nicholaos C. Bellos, MD PA, Dallas

Diversified Medical Practices, Houston

Valley AIDS Council, Harlingen

AltaMed Health Services, Los Angeles

Providence Clinical Research, Burbank

CSI Clinical Trials, Inc., Fountain Valley

Benchmark Clinical Research, San Francisco

Alta Bates Summit Medical Center, East Bay AIDS Center, Oakland

Northern California Research, Carmichael

Alabama Vaccine Research Clinic; University of Alabama at Birmingham, Birmingham

Indiana University School of Medicine; Division of Infectious Disease, Indianapolis

University of Nebraska Medical Center, Omaha

University of Pennsylvania, Philadelphia

Brown Medical School, Providence

Clinical Research P.R., Inc., San Juan

Maternal Infant Studies Center (CEMI), San Juan